Dr Kaier is a general and interventional Cardiologist at Royal Papworth Hospital, Cambridge. He grew up in Innsbruck, Austria, and prior to starting medical school, he worked as a paramedic for the Austrian Red Cross. He completed my undergraduate medical training at the Medical University Innsbruck (Austria), where he also laid the foundations for his academic career through research investigating ischaemia/reperfusion injury in cardiomyocytes. After moving to the UK in 2008, he completed General Medical and Core Cardiology training in London. He completed a Master of Business Administration (MBA) during his clinical training to enhance the practical delivery of managerial roles and contributions to NHS service delivery.
The award of a competitive research fellowship by the British Heart Foundation in January 2015 supported a post-graduate degree at King’s College London. The PhD explored the role of novel biomarkers in ischaemic heart disease and was awarded in March 2019.
After spending a year as Interventional Fellow at Barts Heart Centre, he obtained an NIHR-funded Academic Clinical Lecturer (ACL) post at King’s College London, enabling him to remain research-active whilst expanding the interventional experience in complex angioplasty and the treatment of chronic total occlusions. Dr Kaier trained for an additional 3 years in complex (high-risk indicated) coronary angioplasty (CHIP) and focus on the treatment of chronic total occlusions (CTO). As a result, he is fully trained in general as well as interventional cardiology with a particular focus on CTO PCI. He is accredited in General Cardiology through the European Exam of General Cardiology (EEGC).
Dr Kaier is strongly committed to academic research - he has completed several post-graduate degrees – an MD in ischaemia/reperfusion injury (awarded 2008), Master in Business Administration (MBA, awarded 2017), a BHF-funded PhD in cardiovascular biomarkers (awarded 2019). He has initiated novel research projects, collaborated nationally and internationally with renowned collaborators, and has authored >40 peer-reviewed papers. He has presented at >30 national and international meetings and was first, co-applicant or clinical collaborator on grant funding exceeding £1,6 million.